Advertisement
Home 2019 April

Monthly Archives: April 2019

High resting heart rate is associated with an increased risk for death and cardiovascular events in men

High Resting Heart Rate Linked to Increased Cardiac Risk in Men

0
Risk for all-cause death, CVD, CHD increased with RHR >75 and with increase in RHR over time
Three simple measurements may predict metabolic syndrome in older patients

Measures May Predict Metabolic Syndrome in Older Adults

0
Best performance seen with sagittal abdominal diameter, SAD/height, and conicity index
For patients with amyotrophic lateral sclerosis

African-Americans With ALS Survive Longer Than Caucasians

0
Difference no longer significant when outcome is death or tracheostomy and invasive ventilation
There is a strong positive association between body mass index and incident Hodgkin lymphoma

J-Shaped Association Seen for BMI, Hodgkin Lymphoma

0
Strong positive association noted, with incidence increasing in BMIs greater than 24.2 kg/m²
Financial incentives do not increase response rates among patients mailed at-home colorectal cancer screening tests

Financial Incentives Do Not Boost Use of At-Home CRC Screening Tests

0
$10 incentives used in the study may have been too small to garner a response
The first generic naloxone nasal spray to treat opioid overdose has received approval from the U.S. Food and Drug Administration.

FDA Approves First Generic Nasal Spray Against Opioid Overdose

0
Product is also first generic naloxone nasal spray approved for use by people without medical training
An informational film can improve knowledge and reduce decisional conflict for individuals considering participating in lung cancer screening

Informational Film Improves Knowledge on Lung Cancer Screening

0
Mean objective and subjective knowledge improved; higher decisional certainty seen with film
Daily atorvastatin is safe for the primary prevention of cardiovascular events (CVE) in patients with rheumatoid arthritis

Statins Safe, Effective in Rheumatoid Arthritis Patients

0
However, cardiovascular event rates are low, do not require a primary prevention strategy for all patients
Atrasentan is associated with a reduced risk for renal events in patients with type 2 diabetes and chronic kidney disease

Atrasentan Tied to Lower Risk for Kidney Events in T2DM With CKD

0
Reduced risk seen for primary composite renal end point event; more frequent fluid retention, anemia reported
Increased screen time in preschool is associated with increased odds of clinically significant externalizing problems and clinically significant inattention problems

Increased Screen Time in Preschool Tied to Worse Inattention

0
Odds increased for reporting clinically significant externalizing problems, inattention problems